Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00263757 · ClinicalTrials.gov registry record · NA

Atrial Fibrillation Recurrence in Sleep Apnea

A NA study of Atrial Fibrillation and Sleep Apnea, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT00263757 is a NA study of Atrial Fibrillation and Sleep Apnea that has completed, run by Mayo Clinic. The registered enrollment target is 25 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00263757, a NA study of Atrial Fibrillation and Sleep Apnea, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This randomized, controlled trial is designed to test whether treatment of sleep disordered breathing (SDB) with positive airway pressure (PAP) therapy alters the natural history of atrial fibrillation (AF). Patients with recent AF who are now in sinus rhythm, and found to have SDB (obstructive and/or central sleep apnea) by formal sleep study but without complaints of daytime sleepiness, are randomized to PAP therapy to eradicate SDB or to usual care (medical management as prescribed by the patient's cardiologist).

Interventions

  • OTHER Usual Care
  • DEVICE Adaptive Servo-Ventilation

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2009-10
Est. Completion 2012-05
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT00263757

The ClinicalTrials.gov registry entry for NCT00263757 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT00263757 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT00263757 about?

NCT00263757 is a clinical study titled "Atrial Fibrillation Recurrence in Sleep Apnea". This randomized, controlled trial is designed to test whether treatment of sleep disordered breathing (SDB) with positive airway pressure (PAP) therapy alters the natural history of atrial fibrillation (AF). Patients with recent AF who are now in sinus rhythm, and found to have SDB (obstructive and/...

What is the current status of trial NCT00263757?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2009-10. Estimated completion is 2012-05.

What conditions does trial NCT00263757 study?

This clinical trial studies the following conditions: Atrial Fibrillation, Sleep Apnea.

What interventions are being tested in trial NCT00263757?

The interventions under investigation include: Usual Care (OTHER), Adaptive Servo-Ventilation (DEVICE).

Who is sponsoring clinical trial NCT00263757?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00263757 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.